Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ethyl acetate extract - Hanmi Pharmaceutical

Next Previous
X
Search
Drug Profile

Ethyl acetate extract - Hanmi Pharmaceutical

Alternative Names: Acetates; ALS-L1023; McEye; Melissa leaf ethyl acetate dried extract

Latest Information Update: 27 Dec 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator AngioLab Inc
  • Developer AngioLab Inc; Hanmi Pharmaceutical
  • Class Acetates; Eye disorder therapies; Hepatoprotectants; Herbal medicines; Obesity therapies
  • Mechanism of Action Angiogenesis inhibitors; Matrix metalloproteinase inhibitors; Vascular endothelial growth factor A inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Diabetic macular oedema; Diabetic retinopathy; Retinopathy of prematurity

Highest Development Phases

  • Phase II Non-alcoholic steatohepatitis; Wet age-related macular degeneration
  • No development reported Eye disorders; Obesity

Most Recent Events

  • 10 Nov 2023 Efficacy and adverse event data from a phase IIa trial in Non-alcoholic steatohepatitis presented at the 74th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD-023)
  • 26 Aug 2022 AngioLab completes a phase II trial in Non-alcoholic steatohepatitis in South Korea (PO) (NCT04342793)
  • 26 Jul 2022 Ethyl acetate extract is still in phase II trials for Non-alcoholic steatohepatitis in South Korea

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top